StockDrifts LogoStockDrifts

RigaChem Bio 141080

Company
리가켐바이오RigaChem Bio
Insiders
1
Buys
1
Total Value
₩70M ($49K)
Avg Return
+141.18%
Last Filing
2026-03-31

RigaChem Bio (141080) has 1 disclosed insider purchases and 0 disclosed disposals on record, filed by 1 distinct insiders. Together those filings cover ₩70M ($49K) in reported transaction value. The earliest filing StockDrifts holds for RigaChem Bio is dated 2024-03-28; the most recent is 2026-03-31. All of it is parsed from DART D001/D002 insider disclosures, the official disclosure system operated by the Financial Supervisory Service (Korea). Across these filings the average return since disclosure is +141.18%, measured from each filing date to the latest available close.

Price & insider activity (12 months)

Recent insider trades

DateTypeSourceInsiderPositionSharesPrice at filingReturnValue
2026-08-04BUYMarket Buy
김용주
Yongju Kim
Chairman17.7K₩109,900+0.0%₩1.5B ($1.1M)
2026-07-24BUY제3자배정유상증자
PANORIONCORP.LIMITED
-679.6K₩96,100+0.0%₩65.3B ($45.4M)
2026-07-24BUYCB인수
PANORIONCORP.LIMITED
-350.1K₩96,100+0.0%₩33.6B ($23.4M)
2026-03-31SELL임원퇴임
김형석
Hyungseok Kim
Internal director-1.5K₩192,000-5.0%₩286M ($199K)
2024-07-01BUYMarket Buy
김형석
Hyungseok Kim
Internal director940₩74,800+141.2%₩70M ($49K)
2024-03-30BUY유상신주취득
PANORIONCORP.LIMITED
-8.0M₩73,800+144.4%₩587.7B ($408.1M)
2024-03-29BUY신규선임
김형석
Hyungseok Kim
Internal director550₩74,800+141.2%₩41M ($29K)
2024-03-29SELL장외매도
박세진
Sejin Park
president-200.0K₩74,800-141.2%₩15.0B ($10.4M)
2024-03-29SELL장외매도
김용주
Yongju Kim
CEO-1.2M₩74,800-141.2%₩89.8B ($62.3M)
2024-03-29BUY장외매수
PANORIONCORP.LIMITED
-1.4M₩74,800+141.2%₩104.7B ($72.7M)
2024-03-28SELL임원퇴임
조영락
Jo Yeong-rak
Senior Vice President-52.4K₩74,100-143.4%₩3.9B ($2.7M)

Frequently asked questions

Who has been buying RigaChem Bio stock?
1 distinct insiders have filed 1 disclosed insider purchases in RigaChem Bio (141080), most recently on 2026-03-31. Each filer, their role, the number of shares and the price at filing are listed in the table on this page.
How many insider filings does RigaChem Bio have?
RigaChem Bio has 1 buy-side and 0 sell-side disclosures on record, covering ₩70M ($49K) in total reported value, spanning 2024-03-28 to 2026-03-31.
Where does StockDrifts get RigaChem Bio insider data?
From DART D001/D002 insider disclosures — the official filing system run by the Financial Supervisory Service (Korea). StockDrifts parses each disclosure and matches it to daily price history; the original filings remain available directly from DART.
Do insider buys in Korean stocks predict returns?
Not uniformly. StockDrifts analysed 170,720 share-count changes across 56,930 Korean DART filings using cross-sectional alpha at fixed forward horizons, and found returns concentrated in particular signal tiers rather than in insider buying generally.

Source filings

Every trade listed above is disclosed in DART D001/D002 insider disclosures, filed with the Financial Supervisory Service (Korea). View the original DART filings for RigaChem Bio. For how StockDrifts scores these disclosures, see the Korea insider signal tier research, or browse every Korean stock we track.